Albert Einstein College of Medicine and Teva Pharmaceuticals, in collaboration with multiple international institutions, ...

ORLANDO -- New results from the randomized CAHtalyst trials shed light on the benefits of crinecerfont (Crenessity) for adult and pediatric patients with congenital adrenal hyperplasia (CAH), a rare ...

Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

Both coffee and matcha are high in caffeine and antioxidants. While coffee gives you an instant energy kick, matcha offers a ...

Foralumab is the only fully human anti-CD3 monoclonal antibody in clinical development for intranasal delivery. By modulating ...

Corporate and Financial Updates In April 2025, Invivyd secured a $30 million non-dilutive term loan facility with Silicon Valley Bank, a division of First Citizens Bank, supporting balance sheet ...

Chemomab Therapeutics Ltd.(Nasdaq:CMMB), (Chemomab), a clinical-stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced ...

The early use of Blarcamesine shows promise in treating Alzheimer's, boosting Anavex's potential. Click here to read an ...

Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...

Analyzing the permissible scope of an injunction under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit reversed the district court’s prohibitions on an open-label extension (OLE) ...

Contineum Therapeutics, Inc. (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology ...